4//SEC Filing
Rosen Robert 4
Accession 0001209191-18-041384
CIK 0000818033other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 9:01 PM ET
Size
20.6 KB
Accession
0001209191-18-041384
Insider Transaction Report
Form 4
Rosen Robert
DirectorSVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-06-29$7.20/sh+129,469$932,177→ 132,109 total - Sale
Common Stock
2018-06-29$41.39/sh−2,112$87,415→ 2,640 total - Exercise/Conversion
Common Stock
2018-07-02$7.20/sh+95,531$687,823→ 98,171 total - Sale
Common Stock
2018-07-02$38.13/sh−92,131$3,512,918→ 6,040 total - Sale
Common Stock
2018-07-02$38.75/sh−3,400$131,765→ 2,640 total - Sale
Common Stock
2018-06-29$39.14/sh−75,661$2,961,122→ 56,448 total - Sale
Common Stock
2018-06-29$40.17/sh−51,696$2,076,597→ 4,752 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-06-29−129,469→ 695,531 totalExercise: $7.20Exp: 2023-05-01→ Common Stock (129,469 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-07-02−95,531→ 600,000 totalExercise: $7.20Exp: 2023-05-01→ Common Stock (95,531 underlying)
Footnotes (7)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018.
- [F2]The range of sales prices received was $38.75 to $39.75. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F3]The range of sales prices received was $39.775 to $40.70. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F4]The range of sales prices received was $41.075 to $41.45. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F5]The range of sales prices received was $37.50 to $38.50. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F6]The range of sales prices received was $38.55 to $38.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F7]At the date of filing, 412,500 shares of the options granted pursuant to the underlying awards were fully vested and exercisable.
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001555089
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 9:01 PM ET
- Size
- 20.6 KB